Skip to main content

Bellerophon Therapeutics, Inc.

BLPHDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001600132

Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Bellerophon Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of BLPH: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3927−12
Shares2.09M1.31M−780.7K (−37.3%)
Value$10.9M$6.34M−$4.52M (−41.6%)

New holders (6)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to BLPH in Q2 2021
InstitutionSharesValue% of portfolio
ACT Capital Management, LLC25,000$121.0K0.06%
Virtu Financial LLC16,495$80.0K0.01%
Ergoteles LLC13,800$67.0K0.00%
HRT Financial LP13,810$66.0K0.00%
Millennium Management LLC12,243$59.0K0.00%
Rockefeller Capital Management L.P.4,500$21.0K0.00%

Sold out (18)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.